...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: something. anything.
3
Feb 28, 2020 02:21PM
5
Feb 28, 2020 02:37PM
4
Mar 03, 2020 10:46AM
1
Mar 03, 2020 08:19PM

Whoops - read too quickly and assumed it was for 2020.  Well, hopefully they will be presenting something this year!

  

Share
New Message
Please login to post a reply